首页> 外文期刊>Autoimmunity >Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
【24h】

Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.

机译:在表达谷氨酸脱羧酶(GAD)65特异性T细胞受体转基因的NOD小鼠中,选择异常的II类限制性CD8 + T细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

We previously described the generation of non-obese diabetic (NOD) mice expressing a transgenic T cell receptor (TCR) specific for peptide epitope 286-300 of the diabetes related self antigen, glutamic acid decarboxylase (GAD)65 in the context of I-A(g7) class II MHC, that are paradoxically protected from diabetes. In this report, we examine the atypical CD8+ cells in these mice. Unlike typical class II restricted TCR transgenic mice, GAD286 mice have normal numbers of CD8+ cells, half of which express high levels of the transgenic TCR. These MHC mismatched CD8+ cells persist in the periphery and proliferate to GAD286-300 peptide in vitro and in vivo in a class II restricted fashion. Interestingly, the CD8+ tetramer(-) T cells that are expressing endogenous TCR can delay diabetes induction in a transfer model, as we previously showed for CD4+ tetramer+ T cells in these mice. The MHC mismatched CD8+ cells appear to be positively selected in an atypical fashion, in that they do not upregulate CD69 or reexpress CD44, and they escape negative selection. We find that production of these CD8+ cells is not dependent on NOD thymus or high affinity of the TCR, but is dependent on the atypical TCR transgenic thymic environment.
机译:我们先前描述了在IA()(IA g7)II类MHC,具有抗糖尿病功能。在本报告中,我们检查了这些小鼠中的非典型CD8 +细胞。与典型的II类限制性TCR转基因小鼠不同,GAD286小鼠的CD8 +细胞数量正常,其中一半表达高水平的转基因TCR。这些MHC错配的CD8 +细胞在外围和体内以II类限制性方式在体外和体内增殖为GAD286-300肽。有趣的是,表达内源性TCR的CD8 +四聚体(-)T细胞可以在转移模型中延迟糖尿病的诱导,正如我们先前在这些小鼠中对CD4 +四聚体+ T细胞所显示的那样。 MHC错配的CD8 +细胞似乎以非典型方式被阳性选择,因为它们不会上调CD69或重新表达CD44,而且它们可以逃避阴性选择。我们发现这些CD8 +细胞的产生不依赖于NOD胸腺或TCR的高亲和力,而是依赖于非典型的TCR转基因胸腺环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号